Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies

Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential dual EGFR/VEGFR-2 inhibitors with promising antimicrobial activity as well.